Jason

Analyst

Wolfe Research

Equibles does not estimate personal net worth.

About Jason

Jason is recorded as Analyst at Wolfe Research. Jason has spoken on 4 earnings calls across 4 companies, most recently for INVENTIVA on September 28, 2026. Those appearances were for INVENTIVA, Docusign, Inc. (DOCU), Kymera Therapeutics, Inc. (KYMR) and Incyte Corp (INCY). The companies whose calls Jason spoke on are classified in the Healthcare and Technology sectors.

Jason on recent calls

“And we just wanted to ask another question about GLP-1. And do you guys think the baseline GLP-1 subgroup is large enough to meaningfully assess whether Linus Cibrena provides incremental histological benefits on top of the therapy?”

Analyst — Wolfe Research, Inventiva H1 2026 financial report · September 28, 2026

“And I just wanted to ask, how well is the Jackify XR conversion tracking along your internal metrics so far? And do you know when payer reimbursement might kick in and which specific earnings will this specifically impact the most?”

Analyst — Wolfe Research, Incyte Corp Q2 FY2026 Earnings Call · July 28, 2026